SEHK:2269Life Sciences
A Look At WuXi Biologics (SEHK:2269) Valuation After Securing ISO 13485:2016 Certification
WuXi Biologics (Cayman) (SEHK:2269) recently obtained ISO 13485:2016 certification for its medical device quality management system with zero non conformities, an event that draws attention to how quality and compliance feed into its equity story.
See our latest analysis for WuXi Biologics (Cayman).
The ISO 13485:2016 win comes as the share price trades at HK$37.18, with a 1 month share price return of 6.41% and a year to date share price return of 14.26%. Over a longer horizon, the 1 year...